Stockreport

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bi [Read more]